Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Lowering blood pressure reduces risk of developing dementia, research shows

Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.

21 May 2020

Quarantine improves air quality, prevents premature deaths in China

Soon after coronavirus appeared, an all-encompassing quarantine put into effect by the Chinese government slowed the spread of the disease and saved lives, but the quarantine also produced another unanticipated health benefit.

20 May 2020

Fewer COVID-19 patients suffer from stroke than previously reported

Fewer people than previously reported suffer from stroke as a result of COVID-19, a new analysis finds. However, strokes that accompany the pandemic virus, SARS-CoV-2, appear to be more severe.

20 May 2020

Drug combination could eliminate side effects of largely abandoned diabetes treatment

A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.

20 May 2020

Study: Women less likely to have cardiovascular disease, and die of it, than men

A huge study of more than 160,000 people in 21 countries has found that women are less likely to have cardiovascular disease, and die of it, than men.

20 May 2020

Social isolation raises the risk of cardiovascular events and all-cause mortality

Those who are socially isolated are over 40% more likely to have a cardiovascular event, such as a heart attack or stroke, than those who were socially integrated, new research has shown.

20 May 2020

Gene mutation linked to MEF2C haploinsufficiency syndrome

A collaboration between scientists at the Medical University of South Carolina and clinicians at the Greenwood Genetic Center has yielded new findings about how a particular gene might regulate brain development.

19 May 2020

Fewer traffic collisions during shutdown means longer waits for organ donations

On Day Two of the San Francisco Bay Area's stay-at-home orders in March, Nohemi Jimenez got into her car in San Pablo, California, waved goodbye to her 3-year-old son and drove to her regular Wednesday dialysis appointment.

19 May 2020

CU researchers identify new way that nerve cells regenerate and repair after damage

Researchers from the University of Colorado School of Medicine have identified a new way that cells in the central nervous system regenerate and repair following damage.

18 May 2020

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas.

18 May 2020

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.

18 May 2020

COVID-19’s adverse impact on the cardiovascular system

COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper.

15 May 2020

COVID-19 patients at high risk for developing complications associated with blood clots

When researchers from the University of Colorado Anschutz Medical Campus, Aurora, used a combination of two specific blood-clotting tests, they found critically ill patients infected with Coronavirus Disease 2019 (COVID-19) who were at high risk for developing renal failure, venous blood clots, and other complications associated with blood clots, such as stroke.

15 May 2020

Study: Most uncommon infections and major vascular events are likely to be misdiagnosed

New research provides estimates of diagnostic error and serious misdiagnosis-related harm rates for each of the five most frequently misdiagnosed major vascular events, infections, and cancers in the U.S.

15 May 2020

Researchers investigate the troubling trend of heart injury in COVID-19 patients

Researchers are finding about half of all patients with COVID-19 admitted to an intensive care unit have heart damage.

15 May 2020

New treatment discovered to reduce swelling after brain and spinal cord injuries

Scientists have discovered a new treatment to dramatically reduce swelling after brain and spinal cord injuries, offering hope to 75 million victims worldwide each year.

15 May 2020

MU Health Care neurologist publishes recommendations for stroke treatment in COVID-19 patients

A University of Missouri Health Care neurologist has published more than 40 new recommendations for evaluating and treating stroke patients based on international research examining the link between stroke and novel coronavirus (COVID-19).

14 May 2020

Potential targets discovered for COVID-19 therapy

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people.

14 May 2020

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.

13 May 2020

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.

13 May 2020

Stroke News and Research

Further Reading

Lowering blood pressure reduces risk of developing dementia, research shows

Quarantine improves air quality, prevents premature deaths in China

Fewer COVID-19 patients suffer from stroke than previously reported

Drug combination could eliminate side effects of largely abandoned diabetes treatment

Study: Women less likely to have cardiovascular disease, and die of it, than men

Social isolation raises the risk of cardiovascular events and all-cause mortality

Gene mutation linked to MEF2C haploinsufficiency syndrome

Fewer traffic collisions during shutdown means longer waits for organ donations

CU researchers identify new way that nerve cells regenerate and repair after damage

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

COVID-19’s adverse impact on the cardiovascular system

COVID-19 patients at high risk for developing complications associated with blood clots

Study: Most uncommon infections and major vascular events are likely to be misdiagnosed

Researchers investigate the troubling trend of heart injury in COVID-19 patients

New treatment discovered to reduce swelling after brain and spinal cord injuries

MU Health Care neurologist publishes recommendations for stroke treatment in COVID-19 patients

Potential targets discovered for COVID-19 therapy

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News